<rst>
<header>
	<relations>
			<rel name="purpose" type="rst"/>
			<rel name="elaboration" type="rst"/>
			<rel name="preparation" type="rst"/>
			<rel name="manner" type="rst"/>
			<rel name="attribution" type="rst"/>
			<rel name="evidence" type="rst"/>
			<rel name="restatement" type="rst"/>
			<rel name="joint" type="multinuc"/>
			<rel name="sequence" type="multinuc"/>
			<rel name="same_unit" type="multinuc"/>
		</relations>
</header>
<body>
<segment id="1" parent="1001" relname="span">Tom Jefferson</segment>
<segment id="2" parent="1" relname="elaboration">( epidemiologist )</segment>
<segment id="3" parent="1004" relname="span">Tom Jefferson is a British epidemiologist ,</segment>
<segment id="4" parent="3" relname="elaboration">based in Rome , Italy ,</segment>
<segment id="5" parent="1005" relname="joint">[ 1 ]</segment>
<segment id="6" parent="1005" relname="joint">who works for the Cochrane Collaboration .</segment>
<segment id="7" parent="1008" relname="span">Jefferson is an author and editor of the Cochrane Collaboration 's acute respiratory infections group , as well as part of four other Cochrane groups .</segment>
<segment id="8" parent="7" relname="evidence">[ 2 ]</segment>
<segment id="9" parent="1010" relname="span">He is also an advisor to the Italian National Agency for Regional Health Services .</segment>
<segment id="10" parent="9" relname="evidence">[ 2 ]</segment>
<segment id="11" parent="1013" relname="span">In 1999 Jefferson was one of the founding members of the Brighton Collaboration along with Harald Heijbel , Ulrich Heininger , and Elisabeth Loupi .</segment>
<segment id="12" parent="11" relname="evidence">[ 3 ]</segment>
<segment id="13" parent="1016" relname="span">He has worked on Cochrane reviews</segment>
<segment id="14" parent="13" relname="elaboration">examining the effectiveness of the anti-viral oseltamivir and the influenza vaccine .</segment>
<segment id="15" parent="1016" relname="evidence">[ 4 ]</segment>
<segment id="16" parent="1018" relname="preparation">Notable work</segment>
<segment id="17" parent="1018" relname="sequence">In 2009</segment>
<segment id="18" parent="1021" relname="span">Jefferson was hired by the governments of Britain and Australia</segment>
<segment id="19" parent="18" relname="purpose">to update a systematic review of oseltamivir .</segment>
<segment id="20" parent="1021" relname="evidence">[ 4 ]</segment>
<segment id="21" parent="1023" relname="span">Initially he had a great deal of trouble getting results of the original trials .</segment>
<segment id="22" parent="21" relname="evidence">[ 4 ]</segment>
<segment id="23" parent="1026" relname="span">Previous researchers had published trials</segment>
<segment id="24" parent="1027" relname="span">without seeing the underlying data</segment>
<segment id="25" parent="26" relname="attribution">and it appeared</segment>
<segment id="26" parent="1028" relname="span">that some of the published papers used ghost writers .</segment>
<segment id="27" parent="1026" relname="evidence">[ 4 ]</segment>
<segment id="28" parent="1033" relname="span">As the company , Roche ,</segment>
<segment id="29" parent="28" relname="elaboration">that did the trials</segment>
<segment id="30" parent="1032" relname="same_unit">refused to provide data for independent analysis ,</segment>
<segment id="31" parent="1031" relname="same_unit">their conclusions in 2009 were that benefits could not be shown .</segment>
<segment id="32" parent="1031" relname="evidence">[ 4 ]</segment>
<segment id="33" parent="1034" relname="joint">In 2011 Jefferson 's team was provided 22,000 pages of data from the European Medicines Agency</segment>
<segment id="34" parent="1037" relname="span">and Roche eventually provided 3,000 pages of data .</segment>
<segment id="35" parent="34" relname="evidence">[ 4 ]</segment>
<segment id="36" parent="1039" relname="span">In 2012 , Jefferson was the lead author of another Cochrane review of this data</segment>
<segment id="37" parent="36" relname="elaboration">which concluded</segment>
<segment id="38" parent="1040" relname="span">that oseltamivir did not reduce the number of hospitalizations</segment>
<segment id="39" parent="38" relname="elaboration">caused by influenza .</segment>
<segment id="40" parent="1044" relname="attribution">Jefferson said</segment>
<segment id="41" parent="1044" relname="span">that this review also found no evidence</segment>
<segment id="42" parent="41" relname="elaboration">that oseltamivir stopped complications from the disease .</segment>
<segment id="43" parent="1043" relname="evidence">[ 5 ]</segment>
<segment id="44" parent="1045" relname="joint">His views about the effectiveness of influenza vaccines and his outspokenness about them are also controversial ;</segment>
<segment id="45" parent="1048" relname="sequence">at a 2007 meeting on pandemic preparedness</segment>
<segment id="46" parent="1048" relname="sequence">he was shunned by other vaccine researchers</segment>
<segment id="47" parent="1051" relname="span">and ate alone .</segment>
<segment id="48" parent="47" relname="evidence">[ 1 ]</segment>
<segment id="49" parent="1053" relname="span">Reviews</segment>
<segment id="50" parent="1055" relname="attribution">led by Jefferson have concluded</segment>
<segment id="51" parent="1055" relname="span">that there is insufficient evidence</segment>
<segment id="52" parent="53" relname="attribution">to show</segment>
<segment id="53" parent="1056" relname="span">that influenza vaccines reduce mortality or infection rates .</segment>
<segment id="54" parent="1053" relname="evidence">[ 6 ]</segment>
<segment id="55" parent="1060" relname="attribution">He has said</segment>
<segment id="56" parent="1061" relname="span">that the studies</segment>
<segment id="57" parent="56" relname="elaboration">claiming large reductions in mortality rates as a result of the influenza vaccine</segment>
<segment id="58" parent="1060" relname="same_unit">are " rubbish " ,</segment>
<segment id="59" parent="1059" relname="evidence">[ 1 ]</segment>
<segment id="60" parent="1062" relname="span">and that " influenza vaccines are about marketing and not science " .</segment>
<segment id="61" parent="60" relname="evidence">[ 7 ]</segment>
<segment id="62" parent="1066" relname="span">He has called repeatedly for placebo-controlled randomized clinical trials</segment>
<segment id="63" parent="62" relname="purpose">to prove the efficacy of flu vaccines ,</segment>
<segment id="64" parent="1067" relname="span">a position</segment>
<segment id="65" parent="64" relname="elaboration">that most in the field hold as unethical .</segment>
<segment id="66" parent="1065" relname="evidence">[ 1 ]</segment>
<segment id="67" parent="1069" relname="span">His views on flu vaccines are opposed by the medical establishment .</segment>
<segment id="68" parent="67" relname="evidence">[ 1 ]</segment>
<segment id="69" parent="1070" relname="span">Publications</segment>
<segment id="70" parent="1072" relname="span">Jefferson , T ; Alderson , P ;</segment>
<segment id="71" parent="1073" relname="span">Wager , E ; Davidoff , F</segment>
<segment id="72" parent="71" relname="elaboration">( 5 June 2002 ) .</segment>
<segment id="73" parent="74" relname="preparation">" Effects of editorial peer review :</segment>
<segment id="74" parent="1075" relname="span">a systematic review " .</segment>
<segment id="75" parent="1076" relname="span">JAMA . 287 ( 21 ) :</segment>
<segment id="76" parent="75" relname="elaboration">2784 – 6 .</segment>
<segment id="77" parent="1078" relname="preparation">doi :</segment>
<segment id="78" parent="1079" relname="span">10.1001/jama.287.21.2784 .</segment>
<segment id="79" parent="78" relname="elaboration">PMID 12038911 .</segment>
<segment id="80" parent="1081" relname="span">Jefferson , T ; Wager , E ; Davidoff , F</segment>
<segment id="81" parent="80" relname="elaboration">( 5 June 2002 ) .</segment>
<segment id="82" parent="1078" relname="joint">" Measuring the quality of editorial peer review " .</segment>
<segment id="83" parent="1084" relname="span">JAMA . 287</segment>
<segment id="84" parent="83" relname="elaboration">( 21 ) : 2786 – 90 .</segment>
<segment id="85" parent="1086" relname="span">doi :</segment>
<segment id="86" parent="85" relname="elaboration">10.1001/jama.287.21.2786 .</segment>
<segment id="87" parent="1078" relname="joint">PMID 12038912 .</segment>
<segment id="88" parent="1089" relname="span">Jefferson , T ; Di Pietrantonj , C ; Debalini , MG ; Rivetti , A ; Demicheli , V</segment>
<segment id="89" parent="88" relname="elaboration">( July 2009 ) .</segment>
<segment id="90" parent="1091" relname="span">" Inactivated influenza vaccines :</segment>
<segment id="91" parent="90" relname="elaboration">methods , policies , and politics " .</segment>
<segment id="92" parent="1092" relname="span">Journal of Clinical Epidemiology . 62 ( 7 ) :</segment>
<segment id="93" parent="92" relname="elaboration">677 – 86 .</segment>
<segment id="94" parent="1094" relname="span">doi :</segment>
<segment id="95" parent="94" relname="elaboration">10.1016/j . jclinepi.2008.07.001 .</segment>
<segment id="96" parent="1096" relname="preparation">PMID 19124222 .</segment>
<segment id="97" parent="1097" relname="span">Jefferson , T. ; Del Mar , C. ; Dooley , L. ; Ferroni , E. ; Al-Ansary , L. A ; Bawazeer , G. A ; van Driel , M. L ; Foxlee , R. ; Rivetti , A.</segment>
<segment id="98" parent="97" relname="elaboration">( 22 September 2009 ) .</segment>
<segment id="99" parent="1101" relname="span">" Physical interventions</segment>
<segment id="100" parent="99" relname="purpose">to interrupt or reduce the spread of respiratory viruses :</segment>
<segment id="101" parent="1101" relname="elaboration">systematic review " .</segment>
<segment id="102" parent="1102" relname="span">BMJ . 339</segment>
<segment id="103" parent="104" relname="preparation">( sep21 1 ) :</segment>
<segment id="104" parent="1103" relname="span">b3675 – b3675 .</segment>
<segment id="105" parent="1106" relname="span">doi :</segment>
<segment id="106" parent="105" relname="elaboration">10.1136/bmj . b3675 .</segment>
<segment id="107" parent="1096" relname="joint">PMC 2190272 .</segment>
<segment id="108" parent="1096" relname="joint">Chan , An-Wen ; Song , Fujian ;</segment>
<segment id="109" parent="1110" relname="span">Vickers , Andrew ;</segment>
<segment id="110" parent="109" relname="elaboration">Jefferson , Tom ; Dickersin , Kay ; Gøtzsche , Peter C ; Krumholz , Harlan M ; Ghersi , Davina ; van der Worp , H Bart ( January 2014 ) .</segment>
<segment id="111" parent="1096" relname="joint">" Increasing value</segment>
<segment id="112" parent="1113" relname="span">and reducing waste :</segment>
<segment id="113" parent="112" relname="elaboration">addressing inaccessible research " .</segment>
<segment id="114" parent="1115" relname="span">The Lancet . 383</segment>
<segment id="115" parent="114" relname="restatement">( 9913 ) :</segment>
<segment id="116" parent="1115" relname="elaboration">257 – 266 .</segment>
<segment id="117" parent="1117" relname="span">doi :</segment>
<segment id="118" parent="117" relname="elaboration">10.1016/S0140-6736(13)62296-5 .</segment>
<segment id="119" parent="1096" relname="joint">PMC 4533904 .</segment>
<segment id="120" parent="1096" relname="joint">PMID 24411650 .</segment>
<segment id="121" parent="1121" relname="span">Doshi , P. ; Jefferson , T.</segment>
<segment id="122" parent="121" relname="elaboration">( 2 March 2015 ) .</segment>
<segment id="123" parent="1123" relname="joint">" The evidence base for new drugs " .</segment>
<segment id="124" parent="1124" relname="span">BMJ . 350</segment>
<segment id="125" parent="126" relname="preparation">( mar02 6 ) :</segment>
<segment id="126" parent="1125" relname="span">h952 – h952 .</segment>
<segment id="127" parent="128" relname="preparation">doi :</segment>
<segment id="128" parent="1126" relname="span">10.1136/bmj . h952 .</segment>
<group id="1000" type="span" />
<group id="1001" type="span" parent="1002" relname="preparation"/>
<group id="1002" type="multinuc" parent="1000" relname="span"/>
<group id="1003" type="span" parent="1002" relname="joint"/>
<group id="1004" type="span" parent="1003" relname="span"/>
<group id="1005" type="multinuc" parent="1004" relname="evidence"/>
<group id="1008" type="span" parent="1002" relname="joint"/>
<group id="1010" type="span" parent="1002" relname="joint"/>
<group id="1012" type="multinuc" parent="1002" relname="joint"/>
<group id="1013" type="span" parent="1012" relname="sequence"/>
<group id="1015" type="span" parent="1012" relname="sequence"/>
<group id="1016" type="span" parent="1015" relname="span"/>
<group id="1017" type="span" parent="1012" relname="sequence"/>
<group id="1018" type="multinuc" parent="1017" relname="span"/>
<group id="1019" type="multinuc" parent="1018" relname="sequence"/>
<group id="1020" type="span" parent="1019" relname="joint"/>
<group id="1021" type="span" parent="1020" relname="span"/>
<group id="1022" type="multinuc" parent="1019" relname="joint"/>
<group id="1023" type="span" parent="1022" relname="sequence"/>
<group id="1024" type="multinuc" parent="1022" relname="sequence"/>
<group id="1025" type="span" parent="1024" relname="joint"/>
<group id="1026" type="span" parent="1025" relname="span"/>
<group id="1027" type="span" parent="23" relname="manner"/>
<group id="1028" type="span" parent="24" relname="elaboration"/>
<group id="1029" type="multinuc" parent="1024" relname="joint"/>
<group id="1030" type="span" parent="1029" relname="sequence"/>
<group id="1031" type="multinuc" parent="1030" relname="span"/>
<group id="1032" type="multinuc" parent="1031" relname="same_unit"/>
<group id="1033" type="span" parent="1032" relname="same_unit"/>
<group id="1034" type="multinuc" parent="1029" relname="sequence"/>
<group id="1037" type="span" parent="1034" relname="joint"/>
<group id="1038" type="span" parent="1034" relname="joint"/>
<group id="1039" type="span" parent="1040" relname="attribution"/>
<group id="1040" type="span" parent="1038" relname="span"/>
<group id="1041" type="multinuc" parent="1034" relname="joint"/>
<group id="1042" type="span" parent="1041" relname="sequence"/>
<group id="1043" type="span" parent="1042" relname="span"/>
<group id="1044" type="span" parent="1043" relname="span"/>
<group id="1045" type="multinuc" parent="1041" relname="sequence"/>
<group id="1048" type="multinuc" parent="1045" relname="joint"/>
<group id="1051" type="span" parent="1048" relname="sequence"/>
<group id="1052" type="span" parent="1048" relname="sequence"/>
<group id="1053" type="span" parent="1052" relname="span"/>
<group id="1054" type="span" parent="49" relname="elaboration"/>
<group id="1055" type="span" parent="1054" relname="span"/>
<group id="1056" type="span" parent="51" relname="purpose"/>
<group id="1058" type="span" parent="1045" relname="joint"/>
<group id="1059" type="span" parent="1058" relname="span"/>
<group id="1060" type="multinuc" parent="1059" relname="span"/>
<group id="1061" type="span" parent="1060" relname="same_unit"/>
<group id="1062" type="span" parent="1045" relname="joint"/>
<group id="1064" type="span" parent="1045" relname="joint"/>
<group id="1065" type="multinuc" parent="1064" relname="span"/>
<group id="1066" type="span" parent="1065" relname="same_unit"/>
<group id="1067" type="span" parent="1065" relname="same_unit"/>
<group id="1069" type="span" parent="1045" relname="joint"/>
<group id="1070" type="span" parent="1045" relname="joint"/>
<group id="1071" type="multinuc" parent="69" relname="elaboration"/>
<group id="1072" type="span" parent="1071" relname="joint"/>
<group id="1073" type="span" parent="70" relname="elaboration"/>
<group id="1074" type="multinuc" parent="1071" relname="joint"/>
<group id="1075" type="span" parent="1074" relname="joint"/>
<group id="1076" type="span" parent="1074" relname="joint"/>
<group id="1077" type="span" parent="1002" relname="joint"/>
<group id="1078" type="multinuc" parent="1077" relname="span"/>
<group id="1079" type="span" parent="1078" relname="joint"/>
<group id="1081" type="span" parent="1078" relname="joint"/>
<group id="1084" type="span" parent="1078" relname="joint"/>
<group id="1086" type="span" parent="1078" relname="joint"/>
<group id="1089" type="span" parent="1078" relname="joint"/>
<group id="1091" type="span" parent="1078" relname="joint"/>
<group id="1092" type="span" parent="1078" relname="joint"/>
<group id="1093" type="span" parent="1002" relname="joint"/>
<group id="1094" type="span" parent="1095" relname="preparation"/>
<group id="1095" type="span" parent="1093" relname="span"/>
<group id="1096" type="multinuc" parent="1095" relname="span"/>
<group id="1097" type="span" parent="1096" relname="joint"/>
<group id="1100" type="span" parent="1096" relname="joint"/>
<group id="1101" type="span" parent="1100" relname="span"/>
<group id="1102" type="span" parent="1096" relname="joint"/>
<group id="1103" type="span" parent="102" relname="elaboration"/>
<group id="1106" type="span" parent="1096" relname="joint"/>
<group id="1110" type="span" parent="1096" relname="joint"/>
<group id="1113" type="span" parent="1096" relname="joint"/>
<group id="1114" type="span" parent="1096" relname="joint"/>
<group id="1115" type="span" parent="1114" relname="span"/>
<group id="1117" type="span" parent="1096" relname="joint"/>
<group id="1120" type="span" parent="1096" relname="joint"/>
<group id="1121" type="span" parent="1120" relname="span"/>
<group id="1122" type="multinuc" parent="1121" relname="elaboration"/>
<group id="1123" type="multinuc" parent="1122" relname="joint"/>
<group id="1124" type="span" parent="1123" relname="joint"/>
<group id="1125" type="span" parent="124" relname="elaboration"/>
<group id="1126" type="span" parent="1122" relname="joint"/>
	</body>
</rst>
